Telix Makes $2.35 Billion Bet on ITM to Build a Global Powerhouse in Cancer Radiopharmaceuticals
Telix Pharmaceuticals has agreed to merge with Germany’s ITM Isotope Technologies Munich in a transaction potentially worth $2.35 billion, a major expansion designed to strengthen Telix’s position in the rapidly growing market for radioactive medicines used to diagnose and treat cancer. The combination brings together two complementary businesses. Australia-based Telix develops radiopharmaceuticals for cancer imaging […]
Lilly’s New Obesity Pill Wins Approval, but FDA Demands Extra Studies on Liver and Heart Risks
Eli Lilly’s newly approved weight-loss pill has cleared an important regulatory hurdle, but the U.S. Food and Drug Administration is requiring the company to carry out additional safety studies after launch, showing that regulators still want closer scrutiny of the medicine’s risks. Apparently, FDA asked Lilly for more data on possible liver injury linked to […]
